Literature DB >> 27531859

Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple sclerosis.

Lucia Patriarca1, Silvia Torlone1, Fabiana Ferrari1, Caterina Di Carmine2, Rocco Totaro2, Ernesto di Cesare1, Alessandra Splendiani3.   

Abstract

Tumefactive multiple sclerosis is an inflammatory demyelinating disease of the central nervous system. It has recently been described as a rare subtype of multiple sclerosis (MS) characterised by the appearance of solitary or multiple space-occupying lesions associated with imaging characteristics mimicking neoplasm. Atypical features include plaque size >2 cm with mass effect, oedema, and/or ring enhancement on magnetic resonance (MR) images.This study is a retrospective review designed to evaluate the prevalence of tumefactive plaques in a selected population of 440 MS patients referred to our MS centre in Southern Italy between 2005 and 2014. We analysed the radiographic features of lesions ranging in size from 0.5 to 2 cm to establish whether smaller plaques with MR characteristics similar to tumefactive plaques present different symptoms, disease evolution and prognosis. We also aimed to ascertain if MR features suggestive of biological aggressiveness could be useful prognostic criteria for a correct diagnosis of the disease and subsequent treatment. Our data suggest that lesions 0.5-2 cm and >2 cm have similar MR features and clinical evolution.
© The Author(s) 2016.

Entities:  

Keywords:  Multiple sclerosis; magnetic resonance imaging; tumefactive demyelinating lesions

Mesh:

Year:  2016        PMID: 27531859      PMCID: PMC5033102          DOI: 10.1177/1971400916665385

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  24 in total

1.  Pediatric inflammatory diseases. Part I: multiple sclerosis.

Authors:  A Catalucci; M Anselmi; A Splendiani; J D Smith; N Limbucci; F Giangaspero; M Gallucci
Journal:  Neuroradiol J       Date:  2012-12-20

2.  Pediatric Inflammatory Diseases. Part III: Small Vessels Vasculitis.

Authors:  A Splendiani; A Catalucci; N Limbucci; M Turner; T Krings; M Gallucci
Journal:  Neuroradiol J       Date:  2012-12-20

Review 3.  Differential diagnosis of multiple sclerosis: contribution of magnetic resonance techniques.

Authors:  F Triulzi; G Scotti
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-05       Impact factor: 10.154

Review 4.  Natural history of multiple sclerosis: implications for counselling and therapy.

Authors:  Christian Confavreux; Sandra Vukusic
Journal:  Curr Opin Neurol       Date:  2002-06       Impact factor: 5.710

Review 5.  Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.

Authors:  Valentina Felli; Alessandra Di Sibio; Monica Anselmi; Antonio Gennarelli; Patrizia Sucapane; Alessandra Splendiani; Alessia Catalucci; Carmine Marini; Massimo Gallucci
Journal:  Neuroradiol J       Date:  2014-12-01

Review 6.  Tumefactive demyelination: an approach to diagnosis and management.

Authors:  Todd A Hardy; Jeremy Chataway
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-01-19       Impact factor: 10.154

7.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

8.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

9.  Distinct supratentorial lesions mimicking cerebral gliomas.

Authors:  G Wurm; B Parsaei; R Silye; F A Fellner
Journal:  Acta Neurochir (Wien)       Date:  2003-12-09       Impact factor: 2.216

10.  Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge.

Authors:  Hossein Kalanie; Ali Amini Harandi; Reza Bakhshandehpour; Daryoosh Heidari
Journal:  Case Rep Radiol       Date:  2012-07-12
View more
  8 in total

1.  Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.

Authors:  Alessandra Splendiani; Marco Perri; Claudia Marsecano; Valentina Vellucci; Giulia Michelini; Antonio Barile; Ernesto Di Cesare
Journal:  Radiol Med       Date:  2017-09-27       Impact factor: 3.469

2.  Population-based incidence and clinico-radiological characteristics of tumefactive demyelination in Olmsted County, Minnesota, United States.

Authors:  Mahboubeh Fereidan-Esfahani; Paul A Decker; Jeanette E Eckel Passow; Claudia F Lucchinetti; Eoin Patrick Flanagan; William Oliver Tobin
Journal:  Eur J Neurol       Date:  2021-12-09       Impact factor: 6.089

Review 3.  Imaging in Pediatric Multiple Sclerosis : An Iconographic Review.

Authors:  Gonzalo Barraza; Kumaran Deiva; Béatrice Husson; Catherine Adamsbaum
Journal:  Clin Neuroradiol       Date:  2020-07-16       Impact factor: 3.649

4.  Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques.

Authors:  Brainner Campos Barbosa; Edson Marchiori; Caio Leal Leidersnaider; Lara Brandao; Mauricio Castillo
Journal:  Neuroradiol J       Date:  2019-01-22

5.  A Blind Spot in the Diagnostic Field: The Challenging Diagnosis of Tumefactive Multiple Sclerosis.

Authors:  Ramy Mando; Emile Muallem; Shaiva G Meka; Ramona Berghea
Journal:  Case Rep Neurol Med       Date:  2018-06-27

6.  Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments.

Authors:  Staley A Brod; J William Lindsey; Flavia Nelson
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-06-18

7.  When tumefactive demyelination is truly a tumor: case report of a radiographic misdiagnosis.

Authors:  Breanna Taylor; Mallika P Patel; Katherine B Peters
Journal:  CNS Oncol       Date:  2021-01-15

8.  Oral Health Status and Multiple Sclerosis: Classic and Non-Classic Manifestations-Case Report.

Authors:  Céu Costa; Hugo Santiago; Sofia Pereira; Ana Rita Castro; Sandra Clara Soares
Journal:  Diseases       Date:  2022-09-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.